Adjuvant Therapy of Nivolumab Combined With Ipilimumab Versus Nivolumab Alone in Patients With Resected Stage IIIB-D or Stage IV Melanoma (CheckMate 915)
Bristol-Myers Squibb
Jeffrey S Weber; Dirk Schadendorf; Michele Del Vecchio; James Larkin; Victoria Atkinson; Michael Schenker; Jacopo Pigozzo; Helen Gogas; Stéphane Dalle; Nicolas Meyer; Paolo A Ascierto; Shahneen Sandhu; Thomas Eigentler; Ralf Gutzmer; Jessica C Hassel; Caroline Robert; Matteo S Carlino; Anna Maria Di Giacomo; Marcus O Butler; Eva Muñoz-Couselo; Michael P Brown; Piotr Rutkowski; Andrew Haydon; Jean-Jacques Grob; Jacob Schachter; Paola Queirolo; Luis de la Cruz-Merino; Andre van der Westhuizen; Alexander M Menzies; Sandra Re; Tuba Bas; Veerle de Pril; Julia Braverman; Daniel J Tenney; Hao Tang; Georgina V Long